Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials

被引：0
|
作者：
Vijairam Selvaraj
Mohammad Saud Khan
Chirag Bavishi
Kwame Dapaah-Afriyie
Arkadiy Finn
Amos Lal
Eleftherios Mylonakis
机构：
[1] The Miriam Hospital,Division of Medicine
[2] Warren Alpert Medical School of Brown University,Division of Medicine Aff2
[3] Rhode Island Hospital,Division of Cardiology, Cardiovascular Institute
[4] Mayo Clinic,Division of Pulmonary and Critical Care Medicine
[5] Rhode Island Hospital,Division of Infectious Diseases
来源：
Lung | 2021年 / 199卷
关键词：
COVID-19; Tocilizumab; IL-6; Mortality; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：239 / 248
页数：9
相关论文
共 50 条
  • [1] Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials
    Selvaraj, Vijairam
    Khan, Mohammad Saud
    Bavishi, Chirag
    Dapaah-Afriyie, Kwame
    Finn, Arkadiy
    Lal, Amos
    Mylonakis, Eleftherios
    [J]. LUNG, 2021, 199 (03) : 239 - 248
  • [2] The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials
    Chia Siang Kow
    Syed Shahzad Hasan
    [J]. European Journal of Clinical Pharmacology, 2021, 77 : 1089 - 1094
  • [3] The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials
    Kow, Chia Siang
    Hasan, Syed Shahzad
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (08) : 1089 - 1094
  • [4] Tocilizumab in patients hospitalized with COVID-19 pneumonia: systematic review and meta-analysis of randomized controlled trials
    Gupta, Samiksha
    Padappayil, Rana Prathap
    Bansal, Agam
    Daouk, Salim
    Brown, Brent
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (01) : 55 - 60
  • [5] BARICITINIB IN HOSPITALIZED PATIENTS WITH COVID-19: META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Selvaraj, Vijairam
    Finn, Arkadiy
    Lal, Amos
    Carino, Gerardo P.
    [J]. CHEST, 2022, 162 (04) : 972A - 972A
  • [6] FAVIPIRAVIR IN HOSPITALIZED COVID-19 PATIENTS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Naveed, Aiman
    Cheema, Huzaifa
    Shahid, Abia
    Singh, Harpreet
    Kurman, Jonathan
    Rehman, Mohammad Ebad Ur
    Umer, Mohammad
    Sahra, Syeda
    Ahmad, Faran
    Ahmad, Sharjeel
    [J]. CRITICAL CARE MEDICINE, 2024, 52
  • [7] Tocilizumab for COVID-19: A systematic review and meta-analysis of randomized controlled trials
    Boppana, Tarun Krishna
    Mittal, Saurabh
    Madan, Karan
    Mohan, Anant
    Hadda, Vijay
    Guleria, Randeep
    [J]. MONALDI ARCHIVES FOR CHEST DISEASE, 2022, 92 (04)
  • [8] Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials
    Siempos, Ilias I.
    Kalil, Andre C.
    Belhadi, Drifa
    Veiga, Viviane Cordeiro
    Cavalcanti, Alexandre Biasi
    Branch-Elliman, Westyn
    Papoutsi, Eleni
    Gkirgkiris, Konstantinos
    Xixi, Nikoleta A.
    Kotanidou, Anastasia
    Hermine, Olivier
    Porcher, Raphael
    Mariette, Xavier
    [J]. ECLINICALMEDICINE, 2024, 69
  • [9] Statins in hospitalized COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials
    Ren, Yajuan
    Wang, Guizuo
    Han, Dong
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (06)
  • [10] Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials
    Lan, Shao-Huan
    Wang, Chiung-Kai
    Chang, Shen-Peng
    Lu, Li-Chin
    Hung, Shun-Hsing
    Lin, Wei-Ting
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (05) : 773 - 780
12345